March 25, 2020 / 11:45 AM / 5 days ago

BRIEF-Advanz Pharma Posts Q4 Revenue Of $122 Mln vs $117.6 Mln

March 25 (Reuters) - Advanz Pharma Corp Ltd:

* ADVANZ PHARMA CORP. LIMITED ANNOUNCES FOURTH QUARTER AND 2019 RESULTS

* ADVANZ PHARMA CORP - Q4 2019 REVENUE OF $122.0 MILLION, COMPARED TO $117.6 MILLION

* ADVANZ PHARMA CORP - RECORDED ADDITIONAL IMPAIRMENT OF $21.0 MILLION DURING Q4, PRIMARILY RELATED TO PHOTOFRIN ASSET

* ADVANZ PHARMA CORP - Q4 NET LOSS OF $24.6 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below